Dafne Guerrero‐Escalera

Author

National Institute of Genomic Medicine ORCID

Also Known As

D. Guerrero-Escalera, Dafne Guerrero-Escalera, Dafne Guerrero‐Escalera

Publications

Citations

H-Index

Concepts

All Affiliations

National Institute of Genomic Medicine Secretaría de Ciencia, Humanidades, Tecnología e Innovación Instituto Politécnico Nacional Benito Juárez Autonomous University of Oaxaca Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional

About

Dafne Guerrero‐Escalera is an author at National Institute of Genomic Medicine specializing in medicine, transcriptional regulation, and gene expression.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	50
2	Cell Biology	1	1	26
3	Hepatology	1	1	24
4	Pathology	1	1	24
5	Pharmacology	1	1	24

Dafne Guerrero‐Escalera

Publications

Citations

H-Index

Page 1

	Year	Citations
The activation of peroxisome proliferator-activated receptor γ is regulated by Krüppel-like transcription factors 6 & 9 under steatotic conditions Ivonne Escalona-Nández, Dafne Guerrero‐Escalera, A. Estanes-Hernández, Biochemical and Biophysical Research Communications Transcriptional RegulationSystems BiologySignal TransductionSteatotic ConditionsSignaling Pathway	2015	26
Chronic administration of diethylnitrosamine to induce hepatocarcinogenesis and to evaluate its synergistic effect with other hepatotoxins in mice Sergio Fuentes-Hernández, Brisa Rodope Alarcón‐Sánchez, Dafne Guerrero‐Escalera, Toxicology and Applied Pharmacology Synergistic EffectHepatologyMedicineLiver PhysiologyChronic Administration	2019	24
Annexins A2 and A5 are potential early biomarkers of hepatocarcinogenesis Ema Elvira Herrera-López, Dafne Guerrero‐Escalera, Isaac Aguirre-Maldonado, Scientific Reports	2023	18
Nucleoredoxin interaction with flightless‐I/actin complex is differentially altered in alcoholic liver disease Brisa Rodope Alarcón‐Sánchez, Dafne Guerrero‐Escalera, Sandra Rosas‐Madrigal, Basic & Clinical Pharmacology & Toxicology	2020	10
A model of alcoholic liver disease based on different hepatotoxics leading to liver cancer Brisa Rodope Alarcón‐Sánchez, Osiris Germán Idelfonso-García, Dafne Guerrero‐Escalera, Biochemical Pharmacology	2024	10

Page 1